News

Generalized pustular psoriasis, or GPP, is a rare and severe form of the autoimmune disease psoriasis.A GPP flare involves a widespread rash accompanied by pustules — small bumps containing pus ...
Mark G. Lebwohl, MD, gives an overview of generalized pustular psoriasis (GPP) and explains how it differs from the more common plaque psoriasis.
An international consensus statement on generalized pustular psoriasis (GPP) from the International Psoriasis Council (IPC) includes the recommendation that considerations such as body surface ...
But we know with generalized pustular psoriasis [GPP], IL-36 plays a unique role. Talk to us a little bit about what’s different in IL-36 and why is it uniquely positioned for GPP patients.
Generalized pustular psoriasis may be caused or triggered by various factors, including genetic mutations, infections, and certain medications. Generalized pustular psoriasis (GPP) is a severe ...
Stress, infections, and corticosteroid withdrawal are known triggers of generalized pustular psoriasis (GPP). However, doctors cannot attribute every GPP flare to a specific cause. Psoriasis is an ...
The Food and Drug Administration (FDA) has expanded the approval of Spevigo ® (spesolimab-sbzo) to include the treatment of generalized pustular psoriasis (GPP) in adult and pediatric patients 12 ...
Boehringer Ingelheim’s Spevigo (spesolimab) has been recommended by the National Institute for Health and Care Excellence (NICE) to treat generalised pustular psoriasis (GPP) flares.
Three-quarters of patients with generalized pustular psoriasis demonstrated response to treatment with an interleukin-36-targeted therapy as early as 4 weeks, according to a study.“Generalized ...
Source Reference: Choon S, et al "International consensus definition and diagnostic criteria for generalized pustular psoriasis from the International Psoriasis Council" JAMA Dermatol 2024; DOI ...
RIDGEFIELD, Conn., March 7, 2025 /PRNewswire/ -- Today, Boehringer Ingelheim announced new analyses to be presented at the American Academy of Dermatology (AAD) annual meeting in Orlando that ...
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Generalized Pustular Psoriasis (GPP) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This ...